Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Route of Administration
6.1 Transdermal Drug Delivery Systems
6.2 Pulmonary Drug Delivery Systems
6.3 Injectable Drug Delivery Systems
6.4 Oral Drug Delivery Systems
Chapter 7 Market Segmentation, By Geography
7.1 North America
7.1.1 Introduction
7.1.2 United States
7.1.3 Canada
7.1.4 Mexico
7.1.5 Others
7.2 Europe
7.2.1 Introduction
7.2.2 U.K
7.2.3 Spain
7.2.4 Italy
7.2.5 France
7.2.6 Russia
7.2.7 Others
7.3 Asia-Pacific
7.3.1 Introduction
7.3.2 China
7.3.3 India
7.3.4 Japan
7.3.5 Australia & New Zealand
7.3.6 Others
7.4 South America
7.4.1 Introduction
7.4.2 Brazil
7.4.3 Argentina
7.4.4 Others
7.5 The Middle East & Africa
7.5.1 Introduction
7.5.2 South Africa
7.5.3 Others
Chapter 8 Competitive Landscape
8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
8.2 Market Share Analysis
8.3 Strategies Adopted By Top Companies
Chapter 9 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Genzyme Corporation
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiative
9.2. Generex Biotechnology Corporation
9.3. Genentech Inc.
9.4. Cephalon, Inc.
9.5. Celgene Corporation
9.6. Bristol-Myers Squibb
9.7. Boston Scientific
9.8. Boehringer Ingelheim
9.9. Bayer Healthcare Pharmaceuticals
9.10. Baxter International Inc.
9.11. Bausch & Lomb
9.12. AstraZeneca PLC
9.13. Amgen Inc.
9.14. Abbott Laboratories
9.15. 3M Company
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Route of Administration 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
